Active cancer or history of malignancy Pregnancy or breastfeeding Known peptide allergies Athletes subject to anti-doping testing (WADA prohibited) Raynauds disease or phenomenon Cold urticaria (hives from cold) Uncontrolled hypertension Peripheral vascular disease Open wounds (for local application) Pregnancy Cardiovascular conditions Diabetes (especially with neuropathy) Current infections Immunosuppression Blood clotting disorders Quality control issues represent perhaps the greatest practical risk with BPC-157
CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer
Read the full review Neuroscience 23 May 2026 Dihexa for Fibromyalgia & Fibro Fog: Tonmya FDA Aug 2025, BDNF, Neuroinflammation & the 2026 UK Review Rigorous 2026 UK review of Dihexa for fibromyalgia and fibro fog
8, Mehrauli, New Delhi, Delhi, 110030, India Compare With Similar Products Appearance White Clear Liquid White to off-white crystalline powder CAS No 137525-51-0 137525-51-0 56613-88-6 Usage For growth hormones Laboratory/Research Use Only For laboratory use only Storage Room Temperature Other, Store at 2-8C, avoid exposure to sunlight Payment Terms Cash in Advance (CID), Cash Advance (CA), Telegraphic Transfer (T/T), Cheque Cash in Advance (CID) Supply Ability 1000 Per Week 5000 Per Month Molecular Weight 1419.54 g/mol 229.27 g/mol Type Other, Peptide Spray Other, Amino Acid Derivative Grade Other, Research Grade Laboratory Reagent Grade Application Other, Peptide Therapy, Experimental Research Peptide Synthesis, Pharmaceutical Intermediates People Also Viewed
Containers: Use copper-free, low-protein-binding polypropylene tubes for aliquoting
